Pilot Study to Evaluate the Self-Management of Gait, Speech, and Dexterity Symptoms in Parkinson's Disease Using a Smartphone Application

NCT ID: NCT05120609

Last Updated: 2021-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the impact of a smartphone application that delivers at-home therapy exercises on patients' self-management of gait, speech, and dexterity symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Nervous System Diseases Movement Disorders Neurodegenerative Diseases Brain Diseases Central Nervous System Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Parkinson's Application

Subjects will complete at-home allied health therapy exercises delivered through a smartphone application. Subjects will use the application daily for 4 weeks, each daily session takes up to 30 minutes to complete.

Group Type EXPERIMENTAL

Parkinson's Application

Intervention Type DEVICE

The application delivers at-home, tailored allied health exercises (physiotherapy, speech and language therapy, and occupational therapy) for the gait, speech, and manual dexterity symptoms associated with Parkinson's disease.

Digital Placebo

Subjects will have access to a digital placebo application and continue usual care.

Group Type PLACEBO_COMPARATOR

Digital Placebo Application

Intervention Type DEVICE

The application is designed to provide a method of capturing outcome measures without providing access to the therapy exercises.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Parkinson's Application

The application delivers at-home, tailored allied health exercises (physiotherapy, speech and language therapy, and occupational therapy) for the gait, speech, and manual dexterity symptoms associated with Parkinson's disease.

Intervention Type DEVICE

Digital Placebo Application

The application is designed to provide a method of capturing outcome measures without providing access to the therapy exercises.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female subjects at least 30 years of age or older,
* History of idiopathic Parkinson's Disease (Hoehn and Yahr stage of II-IV),
* Normal joint range of motion in both legs,
* Able to walk independently for 10 feet with or without an assistive device,
* Parkinson's gait and mild to moderate speech impairment,
* No history of vestibular disease,
* No evidence of dementia (MMSE ≥24),
* Clear benefit from Levodopa,
* Agrees to Beats Medical Application Privacy Policy and Terms of Use,
* Access to an iPhone 7 or higher to use the Beats Medical applications.

Exclusion Criteria

* Medical condition for which exercise is contraindicated,
* History or evidence of neurological deficit other than Parkinson's Disease that could interfere, such as previous stroke or muscle disease,
* History or evidence of orthopaedic or muscular problems,
* Subject is currently enrolled in a study to evaluate an investigational drug or device,
* Subject unable or unwilling to provide informed consent,
* Vulnerable populations as deemed inappropriate for the study by site Principal Investigator,
* History of falls in the past 6 months,
* Pregnancy,
* Current or previous use of the Beats Medical Parkinson's application.
Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beats Medical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Meridian Clinical Research

Norfolk, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Armistead Williams, MD

Role: CONTACT

Phone: 757-226-0655

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Armistead Williams, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1001

Identifier Type: -

Identifier Source: org_study_id